EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Costunolide alleviates hyperglycaemia‐induced diabetic cardiomyopathy via inhibiting inflammatory responses and oxidative stress

Bo Jin, Yi Chen, Jiong Wang, Yue Chen, Mengpei Zhang, Jianxiong Huang, Yi Wang iD

Journal of Cellular and Molecular Medicine · 2023

DOI: 10.1111/jcmm.17686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Bo Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Xiangshan Hospital of Wenzhou Medical University, Ningbo, China. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Hyperglycemia, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperglycaemia‐induced myocardial injury promotes the induction of heart failure in diabetic patients. Impaired antioxidant capability and sustained chronic inflammation play a vital role in the progression of diabetic cardiomyopathy (DCM). Costunolide (Cos), a natural compound with anti‐inflammatory and antioxidant properties, has exhibited therapeutic effects in various inflammatory diseases. However, the role of Cos in diabetes‐induced myocardial injury remains poorly understood. In this study, we investigated the effect of Cos on DCM and explored the potential mechanisms. C57BL/6 mice were administered intraperitoneal streptozotocin for DCM induction. Cos‐mediated anti‐inflammatory and antioxidation activities were examined in heart tissues of diabetic mice and high glucose (HG)‐stimulated cardiomyocytes. Cos markedly inhibited HG‐induced fibrotic responses in diabetic mice and H9c2 cells, respectively. The cardioprotective effects of Cos could be correlated to the reduced expression of inflammatory cytokines and decreased oxidative stress. Further investigations demonstrated Cos reversed diabetes‐induced nuclear factor‐κB (NF‐κB) activation and alleviated impaired antioxidant defence system, principally via activation of nuclear factor‐erythroid 2 p45‐related factor‐2 (Nrf‐2). Cos alleviated cardiac damage and improved cardiac function in diabetic mice by inhibiting NF‐κB‐mediated inflammatory responses and activating the Nrf‐2‐mediated antioxidant effects. Therefore, Cos could be a potential candidate for the treatment of DCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesHyperglycemiaDiabetes Mellitus, ExperimentalMiceAnimalsAntioxidantsNF-kappa BSignal TransductionMice, Inbred C57BLOxidative StressMyocytes, CardiacAnti-Inflammatory AgentsLactonesSesquiterpenes

Stichwörter der Autor:innen

CostunolideNF-κBNrf-2diabetic cardiomyopathyinflammationoxidative stress

Substanzen

AntioxidantsNF-kappa BAnti-Inflammatory AgentscostunolideLactonesSesquiterpenes

Autor:innen und Institutionen

  • The Affiliated Xiangshan Hospital of Wenzhou Medical University, Ningbo, China.
  • Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Yi Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Jin, B., Chen, Y., Wang, J., Chen, Y., Zhang, M., Huang, J., & Wang, Y. (2023). Costunolide alleviates hyperglycaemia‐induced diabetic cardiomyopathy via inhibiting inflammatory responses and oxidative stress. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17686

Vancouver

Jin B, Chen Y, Wang J, Chen Y, Zhang M, Huang J, et al. Costunolide alleviates hyperglycaemia‐induced diabetic cardiomyopathy via inhibiting inflammatory responses and oxidative stress. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17686

BibTeX
@article{Jin2023,
  author = {Jin, Bo and Chen, Yi and Wang, Jiong and Chen, Yue and Zhang, Mengpei and Huang, Jianxiong and Wang, Yi},
  title = {Costunolide alleviates hyperglycaemia‐induced diabetic cardiomyopathy via inhibiting inflammatory responses and oxidative stress},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  doi = {10.1111/jcmm.17686}
}
Kostenlos starten →